Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
11,564,180
-
Share change
-
-51,872
-
Total reported value
-
$36,658,101
-
Price per share
-
$3.17
-
Number of holders
-
33
-
Value change
-
-$194,819
-
Number of buys
-
11
-
Number of sells
-
22
Institutional Holders of DICERNA PHARMACEUTICALS INC - COM (DRNA) as of Q2 2017
As of 30 Jun 2017,
DICERNA PHARMACEUTICALS INC - COM (DRNA) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,564,180 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, FMR LLC, RTW INVESTMENTS, LP, 683 Capital Management, LLC, EcoR1 Capital, LLC, Palo Alto Investors, LLC, RENAISSANCE TECHNOLOGIES LLC, EVENTIDE ASSET MANAGEMENT, LLC, VANGUARD GROUP INC, and UBS Group AG.
This page lists
33
institutional shareholders reporting positions in this security
for the Q2 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.